FDA IND Approval

MedRegen LLC   →  Blog Large Image   →  Medregen   →  FDA IND Approval
31
Dec
Date December 31, 2020
Categories Medregen

FDA IND Approval

MedRegen is proud to announce that the FDA has approved the IND applications for a combined phase 1/2 clinical trial with MRG-001 for the treatment of COVID-19 disease.

Author medregen